Lipid lowering efficacy of rosuvastatin
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
Primary objective
To quantify the effects of various doses of rosuvastatin on serum total cholesterol, LDL‐cholesterol, HDL‐cholesterol and triglycerides in subjects with and without evidence of cardiovascular disease. The primary focus of the review will be on the mean per cent change of LDL‐cholesterol.
Secondary objective
To quantify the variability of the effect of various doses of rosuvastatin.
To quantify withdrawals due to adverse effects in the randomized placebo controlled trials.